Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib

Simple item page
dc.contributor.authorBuchler Tomášcs
dc.contributor.authorKopecká Mariecs
dc.contributor.authorZemánková Anežkacs
dc.contributor.authorWiesnerová Markétacs
dc.contributor.authorStrecková Evacs
dc.contributor.authorRozsypalová Anetacs
dc.contributor.authorMelichar Bohuslavcs
dc.contributor.authorPoprach Alexandrcs
dc.contributor.authorRichter Igorcs
dc.date.accessioned2021-01-14T18:07:26Z
dc.date.available21-42-2020en
dc.date.available2021-01-14T18:07:26Z
dc.date.issued2020cs
dc.date.updated21-49-2020en
dc.format.extent0cs
dc.identifier.issn15673-679cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/158703
dc.language.isoengcs
dc.relation.ispartofTargeted Oncologyen
dc.relation.ispartofseries0cs
dc.subjectrenal cell cancercs
dc.subjectsarcopeniacs
dc.subjectcabozantinibcs
dc.subjecttoxicitycs
dc.titleSarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinibcs
local.identifier.publikace8030
Files
Collections